Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Jaroslaw Maciejewski is a Hematologist in Cleveland, Ohio. Dr. Maciejewski is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Paroxysmal Cold Hemoglobinuria, Bone Marrow Transplant, and Splenectomy.

Dr. DeZern is a Professor of Oncology and Medicine at The Johns Hopkins University School of Medicine. She is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. DeZern has expertise in aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, acute myeloid leukemia, and bone marrow transplantation. Dr. DeZern received her medical degree at The Johns Hopkins University School of Medicine. She completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology and hematology, as well as obtained a Masters in Clinical Investigations at the Bloomberg School of Public health. Dr. DeZern is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. Dr. DeZern’s principle research activities consist of designing and conducting clinical trials that test investigational new therapies and approaches in the treatment of bone marrow failure (aplastic anemia and myelodysplastic syndromes). She has specific expertise in the use of alternative donor bone marrow transplantation in patients with severe aplastic anemia and trials of novel therapeutics for patients with myelodysplastic syndromes. Additionally, she has taken a rigorous approach to the study of diagnostics and supportive case (such as transfusion practices) in these patient populations. She is or has been the Principal Investigator for a number of multicenter trials in collaboration with the MDS Clinical Research Consortium, the Eastern Co-operative Oncology Group (ECOG)-ACRIN and now the Bone Marrow Trials Clinical Trials Network (BMTCTN). She is the Study Chair for the multi-site BMTCTN study (CHAMP) investigating the role of haploidentical donor transplantation using post-transplantation cyclophosphamide in patients with relapsed several aplastic anemia. Dr. DeZern is the local PI as well as the Deputy Chair for The National MDS Study, a collaborative natural history study of the NHLBI and the NCI. As a clinical investigator with a focus on translation of novel treatments to the clinic, Dr. DeZern’s goal is to improve outcomes for patients with bone marrow failure at the bedside and in her research environment. Dr. Dezern is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Jamile Shammo is a Hematologist in Chicago, Illinois. Dr. Shammo is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Myelodysplastic Syndrome (MDS), Myelofibrosis, and Bone Marrow Aspiration.

Richard Furman is a Hematologist and an Oncologist in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy.

Christophe Legendre practices in Paris, France. Mr. Legendre is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, Kidney Transplant, and Nephrectomy.

Nassim Kamar practices in Toulouse, France. Mr. Kamar is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Hepatitis E, Hepatitis, Cytomegalovirus Infection, Kidney Transplant, and Liver Transplant.

Gerard Socie practices in Paris, France. Mr. Socie is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Aplastic Anemia, Bone Marrow Transplant, and Bone Graft.

Yoshinobu Kanda practices in Saitama, Japan. Mr. Kanda is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Graft Versus Host Disease (GvHD), Febrile Neutropenia, Leukemia, Bone Marrow Transplant, and Bone Graft.

Shinji Nakao practices in Kanazawa, Japan. Mr. Nakao is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Aplastic Anemia, Anemia, Paroxysmal Cold Hemoglobinuria, Bone Marrow Transplant, and Tissue Biopsy.

Phillip Scheinberg is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Scheinberg is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Aplastic Anemia, Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, and Bone Marrow Transplant.

Jin Kim practices in Seoul, Republic of Korea. Kim is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. Their top areas of expertise are Paroxysmal Cold Hemoglobinuria, Paroxysmal Nocturnal Hemoglobinuria (PNH), Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Cardiac Ablation.

Bruno Fattizzo practices in Milan, Italy. Mr. Fattizzo is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Autoimmune Hemolytic Anemia, Anemia, Evans Syndrome, Splenectomy, and Bone Marrow Transplant.

Jack Wetzels practices in Nijmegen, Netherlands. Mr. Wetzels is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Membranous Nephropathy, Glomerulonephritis, Focal Segmental Glomerulosclerosis, Kidney Transplant, and Nephrectomy.

Mohamad Mohty practices in Paris, France. Mr. Mohty is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft.

Christoph Licht practices in Toronto, Canada. Mr. Licht is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Hemolytic-Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, Atypical Hemolytic Uremic Syndrome (aHUS), and Kidney Transplant.

Spero Cataland is a Hematologist in Columbus, Ohio. Dr. Cataland is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Thrombocytopenia, Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, and Splenectomy.

David Dingli is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Dingli is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Smoldering Multiple Myeloma, POEMS Syndrome, and Bone Marrow Transplant. Dr. Dingli is currently accepting new patients.

Regis De Latour practices in Paris, France. Mr. De Latour is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Aplastic Anemia, Bone Marrow Transplant, and Bone Graft.

Veronique Bacchi-Fremeaux practices in Paris, France. Ms. Bacchi-Fremeaux is rated as an Elite expert by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Minus Hemolytic Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, and Kidney Transplant.